Press Release: ReposiTrak, Inc. Declares its Third 10% Increase in its Quarterly Cash Dividend

Dow Jones
2025/06/05

Dividend Growth Reflects Ongoing Commitment to Shareholders

SALT LAKE CITY--(BUSINESS WIRE)--June 05, 2025-- 

ReposiTrak, Inc. (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced its third 10% increase in its quarterly cash dividend in the prior three years. The new dividend of $0.02 per share per quarter (equivalent to $0.08 per share annually) will be paid to shareholders of record as of September 30, 2025, on or about November 14, 2025. Subsequent dividends will be paid within 45 days of each fiscal quarter end.

Randall K. Fields, Chairman and CEO of ReposiTrak commented, "This marks the third time that ReposiTrak has increased its quarterly dividend in the past three years reflecting our financial performance and ongoing commitment to returning more and more capital to our shareholders. Our capital allocation plan is a balanced objective: as we have said, and more importantly delivered for now three consecutive years, our goal is to return 50% of our annual operating cash flow to shareholders through dividends, paying off debt, and share repurchases, while the other 50% will be reserved and allocated to invest in growth while simultaneously maintaining a robust balance sheet. The Board's decision to raise the dividend again is a testament to its confidence in the strength of our business model and the opportunities ahead."

About ReposiTrak:

ReposiTrak (NYSE: TRAK) provides retailers, suppliers, food manufacturers and wholesalers with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements, enhance operational controls and increase sales with unrivaled brand protection. Consisting of three product families -- food traceability, compliance and risk management and supply chain solutions -- ReposiTrak' s integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, please visit https://repositrak.com.

Forward-Looking Statements:

Any statements contained in this press release that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "if", "should" and "will" and similar expressions as they relate to ReposiTrak Inc. are intended to identify such forward-looking statements. ReposiTrak may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see "Risk Factors" in our annual report on Form 10-K, our quarterly report on Form 10-Q, and our other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250605930658/en/

 
    CONTACT:    Investor Relations: 

John Merrill, CFO

investor-relations@repositrak.com

or

FNK IR

Rob Fink

646-809-4048

rob@fnkir.com

 
 

(END) Dow Jones Newswires

June 05, 2025 08:00 ET (12:00 GMT)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10